Muscular Dystrophy & Myositis ( Muscle Inflammation)
It is the disease featuring weakness and inflammation of muscles and muscle pain. The cause of much inflammatory myopathy is unknown i.e. idiopathic. The usual criteria for a diagnosis are weakness in muscles of the head, neck, trunk, upper arms or upper legs. They may be diagnosed by biopsy, MRI or electromyography. The biopsy findings of (i) muscle cell degeneration and regeneration and (ii) chronic inflammatory infiltrates in muscle cells. The goal of treatment is to improve the activities of daily living and muscle strength. The suppression of immune system activity i.e. immunosuppression is the treatment strategy. Every year between 2.18 and 7.7 people per million receive diagnosis. Around 3.2 children per million per year are diagnosed with an average age of onset of seven years.
- Musculoskeletal system
- Symptoms and diagnosis
- Congenital muscular dystrophy
- Distal muscular dystrophy
- Facioscapulohumeral muscular dystrophy
- Limb-girdle muscular dystrophy
- Chronic muscle inflammation
- Muscle pain
- Muscular myositis
Related Conference of Muscular Dystrophy & Myositis ( Muscle Inflammation)
21st World Congress on Vascular Dementia and Neurodegenerative Diseases
12th International Conference and Expo on Physiotherapies, Physical Rehabilitation and Sports Medicine
9th World Physical Medicine and Rehabilitation Conference
14th International Conference on Stress, Mindfulness, Meditation and Resilience
14th International Conference and Expo on Novel Physiotherapies and Physical Rehabilitation
Muscular Dystrophy & Myositis ( Muscle Inflammation) Conference Speakers
Recommended Sessions
- Advances in Myositis Treatment
- Anti Myositis Drugs and Market research
- Healthcare and Pharmaceutical Enterpreneur Meet
- Holistic Approach and Alternative Myositis Treatment Strategies
- Immune Diseases
- Muscular Dystrophy & Myositis ( Muscle Inflammation)
- Myositis Classifications
- Myositis Diagnosis and Clinical Case Reports
- Myositis in Children
- Myositis Treatment - Novel Physiotherapy and Rehabilitation
- Myositis- Insights and Future Research
- Nursing and Post Treatment Care
- Orthopaedic and Rheumatology Surgeries
- Patient Safety
Related Journals
Are you interested in
- Addiction, Drug Abuse, and Recovery - Stress and Mindfulness 2027 (France)
- Anger Management and Negative Outcomes - Stress and Mindfulness 2027 (France)
- Anxiety, Phobias, and Panic Disorders - Stress and Mindfulness 2027 (France)
- Communication Skills and Public Speaking - Stress and Mindfulness 2027 (France)
- Depression, Symptoms, and Trauma - Stress and Mindfulness 2027 (France)
- Emotional Intelligence and Relationships - Stress and Mindfulness 2027 (France)
- Entrepreneurship and Workplace Stress - Stress and Mindfulness 2027 (France)
- Holistic Health and Holistic Medicine - Stress and Mindfulness 2027 (France)
- Humanistic and Existential Psychology - Stress and Mindfulness 2027 (France)
- Lifestyle and Disease Management - Stress and Mindfulness 2027 (France)
- Mental Health and Wellbeing - Stress and Mindfulness 2027 (France)
- Mindfulness and Compassion - Stress and Mindfulness 2027 (France)
- Optimism and Mindset - Stress and Mindfulness 2027 (France)
- Parenting and Child Development - Stress and Mindfulness 2027 (France)
- Personality and Self-Improvement - Stress and Mindfulness 2027 (France)
- Positive Psychology and Happiness - Stress and Mindfulness 2027 (France)
- Psychiatry and Psychiatric Disorders - Stress and Mindfulness 2027 (France)
- Psychology and Psychological Resilience - Stress and Mindfulness 2027 (France)
- Psychotherapy and Counseling - Stress and Mindfulness 2027 (France)
- Self-Care and Personal Wellbeing - Stress and Mindfulness 2027 (France)
- Sleep and Mental Health - Stress and Mindfulness 2027 (France)
- Social Psychology and Group Dynamics - Stress and Mindfulness 2027 (France)
- Stress, Types, Causes, and Management - Stress and Mindfulness 2027 (France)
- Yoga and Meditation - Stress and Mindfulness 2027 (France)
